516 24. Saboo US, Amparo F, Abud TB, Schaumberg DA, Dana R. Vision-Related Quality of Life in Patients with Ocular Graft-versusHost Disease. Ophthalmology. agosto 2015;122(8):1669–74. 25. Kenyon M, Babic A, curatori. The European Blood and Marrow Transplantation Textbook for Nurses [Internet]. Cham: Springer International Publishing; 2018 [citato 12 agosto 2022]. Disponibile su: http://link.springer.com/10.1007/978-3-319-50026-3 26. Saboo US, Amparo F, Shikari H, Dana R. Prevalence of ocular hypertension and glaucoma in patients with chronic ocular graftversus-host disease. Graefes Arch Clin Exp Ophthalmol. maggio 2016;254(5):923–8. 27. Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report. Biol Blood Marrow Transplant. marzo 2015;21(3):389-401.e1. 28. Ogawa Y, Kim SK, Dana R, Clayton J, Jain S, Rosenblatt MI, et al. International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: Proposed Diagnostic Criteria for Chronic GVHD (Part I). Sci Rep. dicembre 2013;3(1):3419. 29. on behalf of the EBMT (European Society for Blood and Marrow Transplantation) Transplant Complications Working Party and the “EBMT−NIH (National Institutes of Health)−CIBMTR (Center for International Blood and Marrow Transplant Research) GvHD Task Force”, Schoemans HM, Lee SJ, Ferrara JL, Wolff D, Levine JE, et al. EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versushost disease assessment. Bone Marrow Transplant. novembre 2018;53(11):1401–15. 30. Alves M, Reinach PS, Paula JS, Vellasco e Cruz AA, Bachette L, Faustino J, et al. Comparison of Diagnostic Tests in Distinct Well-Defined Conditions Related to Dry Eye Disease. Wedrich A, curatore. PLoS ONE. 21 maggio 2014;9(5):e97921. 31. Greinix HT, Loddenkemper C, Pavletic SZ, Holler E, Socié G, Lawitschka A, et al. Diagnosis and Staging of Chronic Graft-versus-Host Disease in the Clinical Practice. Biol Blood Marrow Transplant. febbraio 2011;17(2):167–75. 32. Carpenter PA. How I conduct a comprehensive chronic graft-versus-host disease assessment. Blood. 8 settembre 2011;118(10):2679–87. 33. Carpenter PA, Kitko CL, Elad S, Flowers MED, Gea-Banacloche JC, Halter JP, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant. luglio 2015;21(7):1167–87. 34. Nair S, Vanathi M, Mukhija R, Tandon R, Jain S, Ogawa Y. Update on ocular graft-versus-host disease. Indian J Ophthalmol. 2021;69(5):1038. 35. Abud TB, Amparo F, Saboo US, Di Zazzo A, Dohlman TH, Ciolino JB, et al. A Clinical Trial Comparing the Safety and Efficacy of Topical Tacrolimus versus Methylprednisolone in Ocular Graftversus-Host Disease. Ophthalmology. luglio 2016;123(7):1449–57. 36. Lelli GJ, Musch DC, Gupta A, Farjo QA, Nairus TM, Mian SI. Ophthalmic Cyclosporine Use in Ocular GVHD: Cornea. luglio 2006;25(6):635–8. 37. Jung JW, Lee YJ, Yoon SC, Kim T im, Kim EK, Seo KY. Long-term Result of Maintenance Treatment With Tacrolimus Ointment in Chronic Ocular Graft-Versus-Host Disease. Am J Ophthalmol. marzo 2015;159(3):519-527.e1. 38. Azari AA, Karadag R, Kanavi MR, Nehls S, Barney N, Kim K, et al. Safety and efficacy of autologous serum eye drop for treatment of dry eyes in graft-versus-host disease. Cutan Ocul Toxicol. 3 aprile 2017;36(2):152–6. 39. Tahmaz V, Gehlsen U, Sauerbier L, Holtick U, Engel L, Radojska S, et al. Treatment of severe chronic ocular graft-versushost disease using 100% autologous serum eye drops from a sealed manufacturing system: a retrospective cohort study. Br J Ophthalmol. 6 giugno 2016;bjophthalmol-2015-307666. 40. Zallio F, Mazzucco L, Monaco F, Astori MR, Passera R, Drago G, et al. A Single-Center Pilot Prospective Study of Topical Application of Platelet-Derived Eye Drops for Patients with Ocular Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant. settembre 2016;22(9):1664–70. 41. Sun YC, Chai X, Inamoto Y, Pidala J, Martin PJ, Flowers MED, et al. Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life. Biol Blood Marrow Transplant. settembre 2015;21(9):1687–91. 42. Giaccone L, Felicetti F, Butera S, Faraci D, Cerrano M, Dionisi Vici M, et al. Optimal Delivery of Follow-Up Care After Allogeneic Hematopoietic Stem-Cell Transplant: Improving Patient Outcomes with a Multidisciplinary Approach. J Blood Med. maggio 2020;Volume 11:141–62.
RkJQdWJsaXNoZXIy ODUzNzk5